CompletedPhase 2NCT00041093
Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer
Studying Squamous cell carcinoma of the cervix uteri
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gynecologic Oncology Group
- Principal Investigator
- Agustin Garcia, MS RDNGynecologic Oncology Group
- Intervention
- Docetaxel(drug)
- Enrollment
- 27 target
- Eligibility
- FEMALE
- Timeline
- 2002
Study locations (1)
- Gynecologic Oncology Group, Philadelphia, Pennsylvania, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00041093 on ClinicalTrials.gov